MOORE JOHN R — SEC Form 4 filings
SEC reporting owner CIK 1191702. 8 Form 4 filings on record with FilingPulse; latest filed 2026-08-17.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-09 to 2026-08-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 6 filings — 111,757 shares, $2,910,044 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: sale of 50,000 shares @ $28.37 ($1,418,510) in Edgewise Therapeutics, Inc., filed 2024-09-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | General Counsel | 8 | — | 12 legs · 111,757 sh · $2,910,044 | 27 |
Form 4 filings — MOORE JOHN R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-17 | 4/A | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 5,781 @ $0 · Option exercise (M): 6,718 @ $0 · Sale (S): 2,439 @ $43.81 · Sale (S): 59 @ $44.41 · Sale (S): 99 @ $44.50 · Sale (S): 2,419 @ $43.80 · +4 more | EDGAR |
| 2025-08-14 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 5,781 @ $0 · Sale (S): 2,098 @ $13.39 · Option exercise (M): 5,781 (derivative) @ $0 · Grant/award (A): 26,875 (derivative) @ $0 · Grant/award (A): 161,250 (derivative) @ $0 | EDGAR |
| 2025-05-07 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 5,209 @ $0 · Sale (S): 1,930 @ $16.45 · Option exercise (M): 5,209 (derivative) @ $0 | EDGAR |
| 2024-09-24 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 50,000 @ $0.71 · Sale (S): 50,000 @ $28.37 · Option exercise (M): 20,922 @ $0.71 · Sale (S): 20,922 @ $27.63 · Option exercise (M): 50,000 (derivative) @ $0 · Option exercise (M): 20,922 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 138,750 (derivative) @ $0 · Grant/award (A): 23,125 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 5,208 @ $0 · Sale (S): 1,956 @ $18.91 · Option exercise (M): 5,208 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 17,993 @ $1.93 · Sale (S): 17,993 @ $20.00 · Option exercise (M): 3,813 @ $1.93 · Sale (S): 3,813 @ $20.01 · Option exercise (M): 8,029 @ $1.93 · Sale (S): 8,029 @ $20.01 · +3 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1191702 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →